Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Gan To Kagaku Ryoho ; 45(13): 2450-2452, 2018 Dec.
Artigo em Japonês | MEDLINE | ID: mdl-30692494

RESUMO

We report a case of advanced gastric cancer accompanied with skip lymph node metastasis in the retro portal region only. An 81-year-old man was referred to our hospital because of epigastric pain. CT examination of the abdomen revealed a gastric tumor and a tumor of 3.5 cm in diameter behind the portal vein and pancreatic head, which had high concentrations of FDG(SUVmax=8.5)on PET-CT examination. Thus, we diagnosed lymph node metastasis of the gastric cancer. We performed distal gastrectomyand en bloc resection of regional lymph nodes(D2 plus retro portal and retro pancreatic head nodes). In pathological examinations, the gastric tumor was diagnosed as poorlydifferentiated adenocarcinoma(por1, T3, INF b, ly1, v0). There were no metastatic nodes in perigastric lymph nodes, but the only metastasis was observed in the bulky lymph node, which was indicated by preoperative examinations. Postoperative course was uneventful. The patient is living recurrence-free without adjuvant chemotherapyfor more than 6 years after the operation.


Assuntos
Excisão de Linfonodo , Metástase Linfática , Neoplasias Gástricas , Idoso de 80 Anos ou mais , Humanos , Masculino , Recidiva Local de Neoplasia , Tomografia por Emissão de Pósitrons combinada à Tomografia Computadorizada , Neoplasias Gástricas/patologia , Neoplasias Gástricas/cirurgia
2.
Gan To Kagaku Ryoho ; 44(12): 1129-1131, 2017 Nov.
Artigo em Japonês | MEDLINE | ID: mdl-29394556

RESUMO

We report a case of huge colon cancer accompanied with severe hypoproteinemia. A7 4-year-old woman was referred to our hospital because of abdominal fullness. Blood examinations revealed anemia(hemoglobin 8.8 g/dL)and sever hypopro- teinemia(total protein 4.5 g/dL, albumin 1.1 g/dL). Computed tomography examination of abdomen revealed ascites and large tumor(12.5×10.5 cm)at the right side colon. By further examinations ascending colon cancer without distant metastasis was diagnosed, then we performed right hemicolectomy and primary intestinal anastomosis by open surgery. Ahuge type 1 tumor(18×12 cm)was observed in the excised specimen, which invaded to terminal ileum directly. The tumor was diagnosed moderately differentiated adenocarcinoma without lymph node metastasis(pT3N0M0, fStage II ). Postoperative course was uneventful and serum protein concentration recovered gradually to normal range. Protein leakage from the tumor cannot be proved by this case, so we can't diagnose as protein-losing enteropathy, but we strongly doubt this etiology from postoperative course in this case.


Assuntos
Adenocarcinoma , Neoplasias do Colo/patologia , Hipoproteinemia/etiologia , Adenocarcinoma/complicações , Adenocarcinoma/cirurgia , Idoso , Colectomia , Neoplasias do Colo/cirurgia , Feminino , Humanos , Hipoproteinemia/tratamento farmacológico , Resultado do Tratamento
3.
Gan To Kagaku Ryoho ; 43(12): 2086-2088, 2016 Nov.
Artigo em Japonês | MEDLINE | ID: mdl-28133230

RESUMO

A 76-year-old woman was referred to our hospital because of an abdominal tumor in September 2009. An irregularly shaped large tumor was detected in the right subcostal abdominal cavity on computed tomography, and was diagnosed as advanced gallbladder cancer without distant metastasis following further examination. We then performed a laparotomy. The tumor had invaded directly into the descending portion of the duodenum and transverse colon. We performed a curative resection of the tumor macroscopically. Pathological findings were moderately differentiated tubular adenocarcinoma derived from gallbladder cancer(T3N0M0, Stage III ). Postoperative antineoplasticc hemotherapy was not administered. At least 4 metastaticregions in the liver(segments 1, 5, 7, and 8)were detected using computed tomography 3 months after the operation, and we then initiated oral administration of S-1. After beginning treatment, we observed partial remission at 3 months and continued treatment. We changed the regimen of chemotherapy to gemcitabine 11 months later because of a drug-induced corneal disorder. One after treatment change also continues advertising, and treatment has ended 5 years after the operation. The patient has not received any treatment for the last 6 years and 7 months, and is now in the follow up period.


Assuntos
Adenocarcinoma/tratamento farmacológico , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Neoplasias da Vesícula Biliar/tratamento farmacológico , Neoplasias Hepáticas/tratamento farmacológico , Adenocarcinoma/secundário , Adenocarcinoma/cirurgia , Idoso , Desoxicitidina/administração & dosagem , Desoxicitidina/análogos & derivados , Combinação de Medicamentos , Feminino , Neoplasias da Vesícula Biliar/patologia , Neoplasias da Vesícula Biliar/cirurgia , Humanos , Neoplasias Hepáticas/secundário , Ácido Oxônico/administração & dosagem , Tegafur/administração & dosagem , Resultado do Tratamento , Gencitabina
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...